-
Among patients with coronary heart disease and LDL-cholesterol levels less than 70 mg/dL, there is no incremental clinical benefit from the addition of niacin to statin therapy during a 36-month follow-up, despite improvements in HDL-cholesterol and triglyceride levels.
-
There is still some debate about the relationship between being overweight and cardiovascular (CV) health, since among overweight individuals there is great diversity in levels of CV fitness as well as CV risk factors (e.g., hypertension, diabetes, dyslipidemia).
-
-
Right-sided MCL-1 monitoring lead rhythm strip. Why might beats #4 through #7 be wide?
-
A drug has been approved to treat high plasma levels of methotrexate. Glucarpidase is a bacterial enzyme produced by recombinant DNA technology using genetically modified Exherichia coli. Glucarpidase is a carboxypeptidase enzyme that metabolizes methotrexate to its inactive metabolites. It is marketed by BTG International Inc. as Voraxaze.
-
In people without known cardiovascular disease, an increase in resting heart rate with age was associated with an increased risk of death.
-
I previously shared some thoughts on communication styles and keeping a log of questions along with your answers that come through your Infection Prevention & Control (IP&C) Program.
-
-
State health departments are becoming vital partners with the Centers for Disease Control and Prevention in an increasing national effort to eradicate healthcare associated infections (HAIs).
-
To examine the association between being placed in contact isolation and delirium, Day and colleagues at the University of Maryland Medical Center reviewed administrative data on all patients admitted during a 2-year period ending in 2009.